mTOR as a target for therapy of renal cancer

Clin Adv Hematol Oncol. 2007 Oct;5(10):772-4.
No abstract available

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols
  • Carcinoma, Renal Cell
  • Drug Delivery Systems / methods*
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Kidney Neoplasms / chemistry
  • Kidney Neoplasms / diagnosis
  • Kidney Neoplasms / drug therapy*
  • Prognosis
  • Protein Kinases / drug effects*
  • Protein Kinases / genetics
  • Protein Kinases / physiology
  • TOR Serine-Threonine Kinases

Substances

  • Protein Kinases
  • MTOR protein, human
  • TOR Serine-Threonine Kinases